Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Algernon Pharmaceuticals (TSE:AGN)
:AGN
Holding TSE:AGN?
Track your performance easily
AGN Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.17
Previous CloseN/A
Volume3.18K
Average Volume (3M)41.37K
Market Cap
C$1.60M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.39M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Jan 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding21,301,180
10 Day Avg. Volume40,637
30 Day Avg. Volume41,373
Standard Deviation0.36
R-Squared0.00115
Alpha0.00300
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Algernon Pharmaceuticals Inc News
PremiumCompany Announcements
Algernon Pharmaceuticals Secures Patent for Lead CKD Drug
PremiumCompany Announcements
Algernon Pharmaceuticals Extends Warrant Expiry Date
PremiumCompany Announcements
Algernon Pharmaceuticals Secures Funding Through Private PlacementPremiumCompany Announcements
Algernon Pharmaceuticals Boosts Private Placement
PremiumCompany Announcements
Algernon Pharmaceuticals Launches Private Placement
PremiumCompany Announcements
Algernon Pharmaceuticals Completes Key Funding Round
PremiumCompany Announcements
Algernon Pharmaceuticals Boosts Private PlacementOptions Prices
Currently, No data available
---
Ownership Overview
AGN FAQ
What was Algernon Pharmaceuticals’s price range in the past 12 months?
Algernon Pharmaceuticals lowest stock price was C$0.06 and its highest was C$0.17 in the past 12 months.
What is Algernon Pharmaceuticals’s market cap?
Algernon Pharmaceuticals’s market cap is C$1.60M.
When is Algernon Pharmaceuticals’s upcoming earnings report date?
Algernon Pharmaceuticals’s upcoming earnings report date is Jan 23, 2025 which is in 8 days.
How were Algernon Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Algernon Pharmaceuticals overvalued?
According to Wall Street analysts Algernon Pharmaceuticals’s price is currently Overvalued.
Does Algernon Pharmaceuticals pay dividends?
Algernon Pharmaceuticals does not currently pay dividends.
What is Algernon Pharmaceuticals’s EPS estimate?
Algernon Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Algernon Pharmaceuticals have?
Algernon Pharmaceuticals has 21,301,180 shares outstanding.
What happened to Algernon Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Algernon Pharmaceuticals?
Currently, no hedge funds are holding shares in TSE:AGN
---
Company Description
Algernon Pharmaceuticals
Algernon Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the development of repurposed therapeutic drugs. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
---
Technical Analysis
Algernon Pharmaceuticals
―
Relmada Therapeutics
―
Alkermes
―
Amgen
―
Arrowhead Pharmaceuticals
―
Axsome Therapeutics
―
Tiziana Life Sciences
―
---